Japan vs Jordan: Cancer death rates in children under 10 years old
Japan
1.6 deaths per 100,000 people
in 2022
Jordan
1.61 deaths per 100,000 people
in 2018
Japan rank
82nd
Jordan rank
81st
Cancer death rates in children under 10 years old over time
- Japan
- Jordan
How they compare
Jordan currently reports 1.61 deaths per 100,000 people against 1.6 deaths per 100,000 people in Japan, a difference of 0.01 deaths per 100,000 people.
The two have swapped places 1 time across 9 shared years of data; in 2008 it was Jordan ahead.
Japan ranks 82nd and Jordan ranks 81st of 110 countries.
Across the 2 decades both report, Japan averaged higher in 1 and Jordan in 1.
Head to head by decade
| Decade | Japan | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.72 deaths per 100,000 people | 2.39 deaths per 100,000 people | 0.6629 deaths per 100,000 people | Jordan |
| 2010s | 1.92 deaths per 100,000 people | 1.5 deaths per 100,000 people | 0.4166 deaths per 100,000 people | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cancer death rates in children under 10 years old, Japan or Jordan?
- Jordan, at 1.61 deaths per 100,000 people against 1.6 deaths per 100,000 people in Japan as of 2018.
- What is the difference in cancer death rates in children under 10 years old between Japan and Jordan?
- 0.01 deaths per 100,000 people, with Jordan ahead.
- How many years of comparable data are there for Japan and Jordan?
- 9 years are reported by both, from 2008 to 2018.
- How do Japan and Jordan rank globally for cancer death rates in children under 10 years old?
- Japan ranks 82nd and Jordan ranks 81st of 110 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Cancer death rates in children under 10 years old. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms per 100,000 people in both sexes aged 10-14 years.